Skip to content

Clinical Observation on Intervention of Cancer Cachexia Syndrome by Approved Traditional Chinese Medicine (Matrine and Kanglaite)

Clinical Observation on Intervention of Cancer Cachexia Syndrome by Approved Traditional Chinese Medicine (Matrine and Kanglaite)

Status
Recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OPC-17012609
Enrollment
Unknown
Registered
2017-09-07
Start date
2017-09-01
Completion date
Unknown
Last updated
2017-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Cachexia

Interventions

Intervention group:Matrine injection or Kanglaite injection
Control group:Methylphenidate tablets

Sponsors

Shanghai Jiaotong University Affiliated Sixth People 's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Diagnosis: 1. clear colon cancer, lung cancer, gastric cancer and pancreatic cancer histopathological diagnosis; 2. 6 months weight loss ? 5%; or body mass index 2%. Inclusion criteria: 1. in line with the diagnosis and treatment of malignant tumor in the middle and late stage; 2. expected survival time longer than 6 months; 3. aged 18 to 80 years old; 4. ECOG score ? 3 points; 5. meet the Qi-Xue deficiency of traditional Chinese medicine syndrome: diet reduced, pale yellow, knee weakness, mental fatigue, long illness wasting. 6volunystary treatment, informed consent and good compliance

Exclusion criteria

Exclusion criteria: 1. pregnant women; 2. gastrointestinal obstruction; 3. thrombosis history; 4. diabetes, hypertension, mental illness, severe cardiovascular and cerebrovascular disorders; 5. moderate and severe liver and kidney dysfunction; 6. treatment wound cause weight and metabolic changes (such as high dose of hormones).

Design outcomes

Primary

MeasureTime frame
Quality of life Score;Body weight Change;

Secondary

MeasureTime frame
Nutrition status(PG-SGA score);KPS score;Pain score;Survival time;GPS Score;Chinese medicine syndrome score;ECOG Score;grip strength of non dominant hand;IL-6;

Countries

China

Contacts

Public ContactGuo Cheng

Shanghai Jiaotong University Affiliated Sixth People 's Hospital

guopharm@126.com+86 18930177555

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026